FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CGMP Violations at Nartex Laboratories

[ Price : $8.95]

FDA warns Mexicos Nartex Laboratories about CGMP violations in its production of finished drugs.

Positive Trial Results for Amgens Tezepelumab

[ Price : $8.95]

Amgen and AstraZeneca say their investigational asthma drug tezepelumab achieved positive results in the Phase 3 NAVIGATOR trial.

Senators Want Info on FDA Foreign Drug Inspections

[ Price : $8.95]

Sens. Warren and Smith ask FDA for information on what it needs to adequately conduct foreign drug inspections during the pandemic...

Guide on Assessing Drug User Fees

[ Price : $8.95]

Federal Register notice: FDA makes available a revised final guidance on Assessing User Fees Under the Prescription Drug User Fee ...

Guide on Microneedling Product Regulatory Considerations

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Regulatory Considerations for Microneedling Products.

Diversity in Trials Final Guidance

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Enhancing the Diversity of Clinical Trial Populations Elig...

Supernus Talking with FDA on Two Submissions

[ Price : $8.95]

Supernus Pharmaceuticals says it has received a complete response letter and refusal to file letter from FDA for two NDAs and will...

OPDP Revising Drug Promo Core Launch Reviews

[ Price : $8.95]

CDER Office of Prescription Drug Promotion acting director Catherine Gray says that beginning next year the Office is revising its...

Stryker Trevo XP ProVue Retriever Recall is Class 1

[ Price : $8.95]

FDA says the Stryker Neurovascular recall of its Trevo XP ProVue Retriever due to a core wire that may break or separate during us...

CDER Finds Ways to Streamline Schizophrenia Drug Trials

[ Price : $8.95]

CDER researchers say it may be possible to streamline clinical trials for drugs to treat schizophrenia by cutting the trial length...